as 11-15-2024 4:00pm EST
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Founded: | 1985 | Country: | United States |
Employees: | N/A | City: | MARLBOROUGH |
Market Cap: | 18.9B | IPO Year: | 1990 |
Target Price: | $89.25 | AVG Volume (30 days): | 1.7M |
Analyst Decision: | Buy | Number of Analysts: | 12 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 2.92 | EPS Growth: | 49.92 |
52 Week Low/High: | $67.59 - $84.67 | Next Earning Date: | 11-04-2024 |
Revenue: | $3,987,600,000 | Revenue Growth: | -1.26% |
Revenue Growth (this year): | 1.73% | Revenue Growth (next year): | 4.32% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Oberton Karleen Marie | HOLX | Chief Financial Officer | Aug 29 '24 | Sell | $80.56 | 52,679 | $4,243,662.20 | 84,042 |
HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Business Wire
3 days ago
Argus Research
6 days ago
Argus Research
6 days ago
Zacks
9 days ago
Zacks
9 days ago
Zacks
9 days ago
Morningstar Research
12 days ago
The information presented on this page, "HOLX Hologic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.